Search Results - "MacEwan, G."

Refine Results
  1. 1

    Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings by Panenka, William J, Procyshyn, Ric M, Lecomte, Tania, MacEwan, G. William, Flynn, Sean W, Honer, William G, Barr, Alasdair M

    Published in Drug and alcohol dependence (01-05-2013)
    “…Abstract Methamphetamine (MA) is a highly addictive psychostimulant drug that principally affects the monoamine neurotransmitter systems of the brain and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Predictors and profiles of treatment non-adherence and engagement in services problems in early psychosis by Lecomte, Tania, Spidel, Alicia, Leclerc, Claude, MacEwan, G. William, Greaves, Caroline, Bentall, Richard P

    Published in Schizophrenia research (01-07-2008)
    “…Abstract Treatment adherence in early psychosis individuals is considered problematic. Some studies have tried to understand reasons for medication…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The need for speed : an update on methamphetamine addiction by BARR, Alasdair M, PANENKA, William J, MACEWAN, G. William, THORNTON, Allen E, LANG, Donna J, HONER, William G, LECOMTE, Tania

    Published in Journal of psychiatry & neuroscience (01-09-2006)
    “…The psychostimulant methamphetamine (MA) is a highly addictive drug that has surged in popularity over the last decade in North America. A burgeoning number of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Rasch analysis of the beck depression inventory in a homeless and precariously housed sample by Cho, Lianne L., Jones, Andrea A., Gao, Chloe, Leonova, Olga, Vila-Rodriguez, Fidel, Buchanan, Tari, Lang, Donna J., MacEwan, G. William, Procyshyn, Ric M., Panenka, William J., Barr, Alasdair M., Thornton, Allen E., Gicas, Kristina M., Honer, William G., Barbic, Skye P.

    Published in Psychiatry research (01-08-2023)
    “…•The BDI satisfies Rasch model expectations after the removal of Item 19 (Weight Loss).•Cognitive and somatic symptoms represent a milder depressive condition,…”
    Get full text
    Journal Article
  11. 11

    Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients by Goghari, Vina M, Smith, Geoffrey N, Honer, William G, Kopala, Lili C, Thornton, Allen E, Su, Wayne, MacEwan, G. William, Lang, Donna J

    Published in Schizophrenia research (01-09-2013)
    “…Abstract Atypical antipsychotic medications generally maintain or increase gray matter amount and functioning. First-episode psychosis patients have lower gray…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    The Assessment of Symptom Severity and Functional Impairment With DSM-IV Axis V by Smith, Geoffrey Norman, Ehmann, Thomas S, Flynn, Sean W, MacEwan, G. William, Tee, Karen, Kopala, Lili C, Thornton, Allen E, Schenk, Christian H, Honer, William G

    Published in Psychiatric services (Washington, D.C.) (01-04-2011)
    “…Objective:The Global Assessment of Functioning scale (GAF) is included as axis V in the DSM-IV multiaxial diagnostic system. The GAF is simple to administer…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20